Clinical Trials Directory

Trials / Sponsors / Daihong Liu

Daihong Liu

Academic / Other · 10 registered clinical trials — 8 currently recruiting.

StatusTrialPhaseStarted
RecruitingStudy of PD-1Ab21-BCMA CAR-T Therapy for Consolidation of Multiple Myelomawith Renal Dysfunction
Multiple Myeloma
Phase 22025-09-29
RecruitingPolymer-lipid Particle-delivered CAR1920 mRNA CAR-T Therapy for Relapsed/Refractory B-cell Lymphoma/Leukemia
B-cell Lymphoma Refractory
Phase 22025-09-01
RecruitingNovel Therapies for Severe Acute GVHD (Graft-versus-host Disease)
GVHD, Acute, Stem Cell Transplant Complications
Phase 22025-06-30
RecruitingExploratory Study of EBV-TCR-T Cell Injection for EBV DNAemia After Allogeneic Hematopoietic Stem Cell Transpl
Epstein-Barr Virus Infection, Post-Transplant Lymphoproliferative Disorder
Phase 1 / Phase 22025-06-01
Active Not RecruitingMaintenance Therapy With Selinexor and Azacitidine in TP53 Mutant AML/MDS After Transplantation
TP53-mutated MDS and AML, Allogeneic Hematopoietic Stem Cell Transplantation
Phase 12025-06-01
RecruitingEBV-AST Cell Injection for EBV-Associated Lymphoproliferative Disorders
Epstein-Barr Virus-Associated Lymphoproliferative Disorders, EBV-Positive Lymphoma
Phase 1 / Phase 22025-06-01
RecruitingNovel First-line Therapies for Grade II Acute GVHD(Graft-versus-host Disease )
GVHD,Acute, Stem Cell Transplant Complications
Phase 22025-06-01
RecruitingEnhancing CAR-T Cell Therapy Efficacy in B-cell Lymphoma Via Chidamide and PD-1 Inhibitor Combination.
Relapsed or Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL)
Phase 22025-05-15
Active Not RecruitingStudy of Targeted CD22/CD19 CAR-T Therapy for First-line Consolidation of B-cell Lymphoma
Lymphoma
Phase 22025-04-01
RecruitingEBV-AST Cell Therapy for EBV-Related Diseases After Stem Cell Transplantation
EBV-DNA Viremia, Post-Transplant Lymphoproliferative Disorder
Phase 1 / Phase 22025-03-26